HF, T., A, v. K., JC, W., RA, O., K, D., MC, F., . . . AR, A. (2023). Quantitative proteomics identifies tumour matrisome signatures in patients with non-small cell lung cancer. Frontiers in oncology, 13, 1194515. https://doi.org/10.3389/fonc.2023.1194515
Chicago Style (17th ed.) CitationHF, Titmarsh, et al. "Quantitative Proteomics Identifies Tumour Matrisome Signatures in Patients with Non-small Cell Lung Cancer." Frontiers in Oncology 13 (2023): 1194515. https://doi.org/10.3389/fonc.2023.1194515.
MLA (9th ed.) CitationHF, Titmarsh, et al. "Quantitative Proteomics Identifies Tumour Matrisome Signatures in Patients with Non-small Cell Lung Cancer." Frontiers in Oncology, vol. 13, 2023, p. 1194515, https://doi.org/10.3389/fonc.2023.1194515.